← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

SENS logoSenseonics Holdings, Inc.(SENS)Earnings, Financials & Key Ratios

SENS•NASDAQ
$5.36
$221M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryDiabetes care and insulin delivery
AboutSenseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.Show more
  • Revenue$35M+56.9%
  • EBITDA-$68M+7.0%
  • Net Income-$69M+12.1%
  • EPS (Diluted)-1.66+33.6%
  • Gross Margin44.71%+1785.0%
  • EBITDA Margin-193.57%+40.7%
  • Operating Margin-193.83%+41.8%
  • Net Margin-196.03%+44.0%
  • ROE-310.68%+62.0%
  • ROIC-324.49%
  • Debt/Equity0.67
  • Interest Coverage-13.80-55.6%
Technical→

SENS Key Insights

Senseonics Holdings, Inc. (SENS) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 48.1%

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 10 (bottom 10%)
  • ✗Shares diluted 32.5% in last year
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

SENS Price & Volume

Senseonics Holdings, Inc. (SENS) stock price & volume — 10-year historical chart

Loading chart...

SENS Growth Metrics

Senseonics Holdings, Inc. (SENS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years98.04%
5 Years48.1%
3 Years29.09%
TTM56.89%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM12.09%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM33.97%

Return on Capital

10 Years-255.02%
5 Years-64.28%
3 Years-74.06%
Last Year-83.59%

SENS Recent Earnings

Senseonics Holdings, Inc. (SENS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 1/12 qtrs (8%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Mar 2, 2026
EPS
$0.46
Est $0.43
-7.0%
Revenue
$14M
Est $14M
+0.4%
Q4 2025
Nov 5, 2025
EPS
$0.43
Est $0.33
-30.3%
Revenue
$8M
Est $14M
-43.1%
Q3 2025
Aug 6, 2025
EPS
$0.40
Est $0.40
+0.0%
Revenue
$8M
Est $6M
+37.8%
Q2 2025
May 8, 2025
EPS
$0.02
Est $0.02
+0.0%
Revenue
$6M
Est $6M
+12.6%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMar 2, 2026
$0.46vs $0.43-7.0%
$14Mvs $14M+0.4%
Q4 2025Nov 5, 2025
$0.43vs $0.33-30.3%
$8Mvs $14M-43.1%
Q3 2025Aug 6, 2025
$0.40vs $0.40+0.0%
$8Mvs $6M+37.8%
Q2 2025May 8, 2025
$0.02vs $0.02+0.0%
$6Mvs $6M+12.6%
Based on last 12 quarters of dataView full earnings history →

SENS Peer Comparison

Senseonics Holdings, Inc. (SENS) competitors in Diabetes care and insulin delivery — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
DXCM logoDXCMDexCom, Inc.Direct Competitor23.29B60.3628.8815.6%19.31%33.83%0.51
ABT logoABTAbbott LaboratoriesDirect Competitor149.97B86.2511.294.59%31.88%27.26%0.32
PODD logoPODDInsulet CorporationDirect Competitor10.61B151.1743.4430.73%10.44%21.38%0.69
TNDM logoTNDMTandem Diabetes Care, Inc.Direct Competitor1.24B18.03-5.937.93%-20.17%-141.98%2.86
GMED logoGMEDGlobus Medical, Inc.Product Competitor12.07B89.2222.7616.65%18.3%12.4%0.03
NVCR logoNVCRNovoCure LimitedProduct Competitor1.88B16.50-13.528.28%-25.66%-50.82%0.85
INVA logoINVAInnoviva, Inc.Product Competitor1.91B22.526.8218.52%118.91%46.47%0.23
LIVN logoLIVNLivaNova PLCProduct Competitor3.62B66.26-14.8910.74%7.47%9.13%0.39

Compare SENS vs Peers

Senseonics Holdings, Inc. (SENS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs DXCM

Most directly comparable listed peer for SENS.

Scale Benchmark

vs LLY

Larger-name benchmark to compare SENS against a more recognizable public peer.

Peer Set

Compare Top 5

vs DXCM, ABT, PODD, TNDM

SENS Income Statement

Senseonics Holdings, Inc. (SENS) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue6.37M18.91M21.3M4.95M13.68M16.39M22.39M22.47M35.26M
Revenue Growth %1819.58%196.77%12.63%-76.77%176.32%19.85%36.62%0.37%56.89%
Cost of Goods Sold9.76M27.06M40.75M22.32M14.49M13.66M19.3M21.94M19.49M
COGS % of Revenue153.11%143.07%191.3%450.9%105.93%83.37%86.19%97.63%55.29%
Gross Profit
-3.38M▲ 0%
-8.15M▼ 140.6%
-19.45M▼ 138.7%
-17.37M▲ 10.7%
-811K▲ 95.3%
2.73M▲ 436.1%
3.09M▲ 13.4%
533K▼ 82.8%
15.76M▲ 2857.4%
Gross Margin %-53.11%-43.07%-91.3%-350.9%-5.93%16.63%13.81%2.37%44.71%
Gross Profit Growth %-932.01%-140.65%-138.74%10.71%95.33%436.13%13.39%-82.76%2857.41%
Operating Expenses52.93M79.43M111.21M61.76M56.37M71.35M78.69M75.38M84.1M
OpEx % of Revenue830.5%419.99%522.11%1248.01%412.22%435.37%351.47%335.42%238.53%
Selling, General & Admin22.19M47.57M72.78M41.35M29.15M31.63M29.94M34.23M52.51M
SG&A % of Revenue348.23%251.51%341.69%835.54%213.19%193.02%133.73%152.33%148.93%
Research & Development30.73M31.86M38.43M20.41M27.22M39.72M48.75M41.14M31.59M
R&D % of Revenue482.27%168.47%180.41%412.47%199.03%242.35%217.74%183.09%89.6%
Other Operating Expenses176K-321K0000000
Operating Income
-56.31M▲ 0%
-87.58M▼ 55.5%
-130.66M▼ 49.2%
-79.13M▲ 39.4%
-57.18M▲ 27.7%
-68.63M▼ 20.0%
-75.6M▼ 10.2%
-74.84M▲ 1.0%
-68.34M▲ 8.7%
Operating Margin %-883.62%-463.06%-613.41%-1598.91%-418.15%-418.74%-337.66%-333.05%-193.83%
Operating Income Growth %-32.71%-55.52%-49.2%39.44%27.74%-20.02%-10.17%1.01%8.69%
EBITDA-56.09M-87.31M-129.66M-77.99M-55.94M-67.64M-74.33M-73.37M-68.25M
EBITDA Margin %-880.05%-461.63%-608.71%-1575.85%-409.09%-412.73%-331.96%-326.48%-193.57%
EBITDA Growth %-32.66%-55.67%-48.51%39.85%28.27%-20.91%-9.88%1.29%6.98%
D&A (Non-Cash Add-back)227.27K270K1M1.14M1.24M985K1.28M1.48M91K
EBIT-56M-85.69M-100.41M-159M-285.75M160.82M-49.28M-70.18M-64.16M
Net Interest Income-2.96M-6.28M-13.21M-15.99M-16.48M-16.88M-5.75M-3.94M-753K
Interest Income135K2M1.93M175K243K1.82M5.36M4.5M4.2M
Interest Expense3.1M8.28M15.14M16.17M16.72M18.7M11.11M8.44M4.95M
Other Income/Expense-2.79M-6.39M15.11M-96.04M-245.29M210.75M15.21M-3.77M-776K
Pretax Income
-59.1M▲ 0%
-93.97M▼ 59.0%
-115.55M▼ 23.0%
-175.17M▼ 51.6%
-302.47M▼ 72.7%
142.12M▲ 147.0%
-60.39M▼ 142.5%
-78.62M▼ 30.2%
-69.11M▲ 12.1%
Pretax Margin %-927.37%-496.86%-542.46%-3539.46%-2211.88%867.16%-269.73%-349.84%-196.03%
Income Tax000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%
Net Income
-59.1M▲ 0%
-93.97M▼ 59.0%
-115.55M▼ 23.0%
-175.17M▼ 51.6%
-302.47M▼ 72.7%
142.12M▲ 147.0%
-60.39M▼ 142.5%
-78.62M▼ 30.2%
-69.11M▲ 12.1%
Net Margin %-927.37%-496.86%-542.46%-3539.46%-2211.88%867.16%-269.73%-349.84%-196.03%
Net Income Growth %-34.53%-59%-22.96%-51.6%-72.68%146.99%-142.49%-30.18%12.09%
Net Income (Continuing)-59.1M-93.97M-115.55M-175.17M-302.47M142.12M-60.39M-78.62M-69.11M
Discontinued Operations000000000
Minority Interest000000000
EPS (Diluted)
-10.20▲ 0%
-12.00▼ 17.6%
-12.20▼ 1.7%
-15.40▼ 26.2%
-14.40▲ 6.5%
-2.20▲ 84.7%
-2.20▲ 0.0%
-2.50▼ 13.6%
-1.66▲ 33.6%
EPS Growth %-4.08%-17.65%-1.67%-26.23%6.49%84.72%0%-13.64%33.6%
EPS (Basic)-10.20-12.00-12.20-15.40-14.406.00-2.20-2.50-1.66
Diluted Shares Outstanding5.8M7.87M9.44M11.4M21.12M30.91M28.4M31.49M41.73M
Basic Shares Outstanding5.8M7.87M9.44M11.4M21.12M23.4M28.4M31.49M41.73M
Dividend Payout Ratio---------

SENS Balance Sheet

Senseonics Holdings, Inc. (SENS) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets44.91M158.11M127.76M30.25M144.41M161.2M130.03M91.44M117.53M
Cash & Short-Term Investments36.45M136.79M95.94M18M129.91M144.01M109.46M74.6M40.23M
Cash Only16.15M136.79M95.94M18M33.46M35.79M75.71M74.6M40.23M
Short-Term Investments20.3M00096.44M108.22M33.75M00
Accounts Receivable3.39M7.1M10.49M2.99M2.42M2.79M6.6M8.08M6.81M
Days Sales Outstanding193.93136.96179.68220.2264.4962.07107.54131.2270.47
Inventory2.99M10.23M16.93M5.28M6.32M7.31M8.78M4.42M6.7M
Days Inventory Outstanding111.88138.01151.6486.38159.14195.18165.9873.55125.5
Other Current Assets48K142K179K200K56K12K1K333K63.79M
Total Non-Current Assets1.03M1.87M5.04M5.67M54.52M16.47M8.19M9M8.74M
Property, Plant & Equipment853K1.75M2M1.56M1.31M1.11M1.18M3.59M4.2M
Fixed Asset Turnover7.47x10.81x10.65x3.18x10.45x14.74x18.91x6.26x8.39x
Goodwill000000000
Intangible Assets0000000481.92K0
Long-Term Investments000051.88M12.25M000
Other Non-Current Assets176K117K3.04M4.12M1.32M3.11M7.01M4.93M4.54M
Total Assets
45.94M▲ 0%
159.97M▲ 248.2%
132.8M▼ 17.0%
35.92M▼ 73.0%
198.93M▲ 453.8%
177.67M▼ 10.7%
138.22M▼ 22.2%
100.44M▼ 27.3%
126.27M▲ 25.7%
Asset Turnover0.14x0.12x0.16x0.14x0.07x0.09x0.16x0.22x0.28x
Asset Growth %106.3%248.19%-16.99%-72.95%453.84%-10.68%-22.21%-27.33%25.72%
Total Current Liabilities23.14M28.89M126.71M16.64M18.39M31.47M17.26M38.85M24.35M
Accounts Payable7.71M4.41M4.29M1.76M1.2M419K4.57M3.21M4.06M
Days Payables Outstanding288.4759.4538.3828.8230.3411.1986.3953.3276
Short-Term Debt10M10M103.79M3.2M2.93M15.58M020.14M0
Deferred Revenue (Current)5.23M628K0000000
Other Current Liabilities3.22M10.17M7.86M5.14M-904K5.51M5.34M5.79M20.29M
Current Ratio1.94x5.47x1.01x1.82x7.85x5.12x7.53x2.35x4.83x
Quick Ratio1.81x5.12x0.87x1.50x7.51x4.89x7.03x2.24x4.55x
Cash Conversion Cycle17.34215.52292.94277.78193.29246.05187.13151.45119.98
Total Non-Current Liabilities15.54M59.83M14.74M163.36M366.07M148.78M85.17M78.14M40.88M
Long-Term Debt14.41M40.97M11.8M57.22M59.8M56.38M41.2M34.7M40.88M
Capital Lease Obligations69K02.28M1.48M579K2.69M6.21M5.79M0
Deferred Tax Liabilities000000000
Other Non-Current Liabilities1.05M18.86M664K104.66M305.69M89.71M37.76M37.66M0
Total Liabilities38.68M88.71M141.45M180M384.46M180.25M102.42M116.99M65.22M
Total Debt24.48M50.97M118.56M62.7M64.21M75.38M47.78M61.05M40.88M
Net Debt8.33M-85.82M22.62M44.69M30.75M39.58M-27.93M-13.54M641K
Debt / Equity3.37x0.72x----1.33x-0.67x
Debt / EBITDA---------
Net Debt / EBITDA---------
Interest Coverage-18.17x-10.57x-8.63x-4.89x-3.42x-3.67x-6.80x-8.87x-13.80x
Total Equity
7.27M▲ 0%
71.26M▲ 880.6%
-8.65M▼ 112.1%
-144.08M▼ 1565.9%
-185.53M▼ 28.8%
-2.58M▲ 98.6%
35.8M▲ 1489.6%
-16.55M▼ 146.2%
61.05M▲ 468.7%
Equity Growth %249.01%880.61%-112.14%-1565.89%-28.77%98.61%1489.6%-146.25%468.75%
Book Value per Share1.259.05-0.92-12.64-8.79-0.081.26-0.531.46
Total Shareholders' Equity7.27M71.26M-8.65M-144.08M-185.53M-2.58M35.8M-16.55M61.05M
Common Stock137K177K203K266K447K480K530K595K41K
Retained Earnings-263.82M-357.79M-473.34M-648.51M-950.99M-808.87M-869.26M-947.87M-1.02B
Treasury Stock000000000
Accumulated OCI-1.04M-1.31M00-212K-678K-11K069K
Minority Interest000000000

SENS Cash Flow Statement

Senseonics Holdings, Inc. (SENS) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations-55.74M-90.77M-136.05M-67.42M-56.08M-66.31M-70.16M-60.47M-59.13M
Operating CF Margin %-874.61%-479.94%-638.69%-1362.34%-410.08%-404.61%-313.37%-269.07%-167.71%
Operating CF Growth %-46.62%-62.85%-49.88%50.44%16.83%-18.25%-5.81%13.82%2.21%
Net Income-59.1M-93.97M-115.55M-175.17M-302.47M142.12M-60.39M-78.62M-69.11M
Depreciation & Amortization227K270K1M1.14M1.24M985K1.28M1.48M91K
Stock-Based Compensation3.99M6.41M8.05M7.31M9.03M8.62M8.67M9.22M10.15M
Deferred Taxes98K-123K061.82M229.17M0000
Other Non-Cash Items453K3.32M-20.07M23.68M8.46M-215.56M-15.76M6.59M-260K
Working Capital Changes-1.41M-6.68M-9.48M13.79M-1.5M-2.47M-3.97M865K0
Change in Receivables-3.13M-3.71M-3.28M7.39M1.01M-478K-2.19M-2.7M-6.76M
Change in Inventory-2.74M-7.44M-6.7M15.82M-1.04M-989K-1.64M696K-2.98M
Change in Payables4.64M-3.4M-122K-2.52M-559K-785K2.3M-1.83M1.22M
Cash from Investing-13.23M19.43M-1.04M-181K-148.75M26.88M89.71M32.84M-53.42M
Capital Expenditures-345K-989K-1.04M-181K-210K-312K-350K-2.24M-1.12M
CapEx % of Revenue5.41%5.23%4.91%3.66%1.54%1.9%1.56%9.96%3.17%
Acquisitions0000210K-27.19M000
Investments---------
Other Investing-12.88M20.41M00-210K27.19M000
Cash from Financing72.07M191.99M96.24M-10.13M220.08M41.76M20.37M26.83M78.19M
Debt Issued (Net)4.92M42.93M72.95M-10.08M-2.84M-2.93M1.25M9.95M0
Equity Issued (Net)1000K1000K1000K550K1000K1000K1000K1000K0
Dividends Paid000000000
Share Repurchases000-26K00000
Other Financing-408K14K-3.47M-601K-227K-1.49M11.74M-1.48M78.19M
Net Change in Cash
3.1M▲ 0%
120.64M▲ 3787.9%
-40.85M▼ 133.9%
-77.73M▼ 90.3%
15.26M▲ 119.6%
2.33M▼ 84.7%
39.92M▲ 1611.7%
-797K▼ 102.0%
-34.36M▼ 4211.5%
Free Cash Flow
-56.08M▲ 0%
-91.76M▼ 63.6%
-137.09M▼ 49.4%
-67.6M▲ 50.7%
-56.29M▲ 16.7%
-66.62M▼ 18.4%
-70.51M▼ 5.8%
-62.7M▲ 11.1%
-60.24M▲ 3.9%
FCF Margin %-880.03%-485.17%-643.59%-1365.99%-411.61%-406.52%-314.93%-279.03%-170.87%
FCF Growth %-45.69%-63.61%-49.4%50.69%16.74%-18.36%-5.84%11.07%3.92%
FCF per Share-9.67-11.66-14.53-5.93-2.67-2.16-2.48-1.99-1.44
FCF Conversion (FCF/Net Income)0.94x0.97x1.18x0.38x0.19x-0.47x1.16x0.77x0.86x
Interest Paid005.23M00004.51M0
Taxes Paid000000000

SENS Key Ratios

Senseonics Holdings, Inc. (SENS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)--4945.69%-239.33%-369.1%----363.59%-817.17%-310.68%
Return on Invested Capital (ROIC)--500%-12643.6%-----252.73%--324.49%
Gross Margin-98.8%-53.11%-43.07%-91.3%-350.9%-5.93%16.63%13.81%2.37%44.71%
Net Margin-13231.93%-927.37%-496.86%-542.46%-3539.46%-2211.88%867.16%-269.73%-349.84%-196.03%
Debt / Equity-3.37x0.72x----1.33x-0.67x
Interest Coverage-26.49x-18.17x-10.57x-8.63x-4.89x-3.42x-3.67x-6.80x-8.87x-13.80x
FCF Conversion0.87x0.94x0.97x1.18x0.38x0.19x-0.47x1.16x0.77x0.86x
Revenue Growth773.68%1819.58%196.77%12.63%-76.77%176.32%19.85%36.62%0.37%56.89%

SENS SEC Filings & Documents

Senseonics Holdings, Inc. (SENS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Mar 12, 2026·SEC

Material company update

Mar 2, 2026·SEC

Material company update

Jan 12, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 2, 2026·SEC

FY 2025

Mar 3, 2025·SEC

FY 2024

Mar 1, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

FY 2025

May 8, 2025·SEC

SENS Frequently Asked Questions

Senseonics Holdings, Inc. (SENS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Senseonics Holdings, Inc. (SENS) reported $35.3M in revenue for fiscal year 2025. This represents a 207294% increase from $0.0M in 2013.

Senseonics Holdings, Inc. (SENS) grew revenue by 56.9% over the past year. This is strong growth.

Senseonics Holdings, Inc. (SENS) reported a net loss of $69.1M for fiscal year 2025.

Dividend & Returns

Senseonics Holdings, Inc. (SENS) has a return on equity (ROE) of -310.7%. Negative ROE indicates the company is unprofitable.

Senseonics Holdings, Inc. (SENS) had negative free cash flow of $65.1M in fiscal year 2025, likely due to heavy capital investments.

Explore More SENS

Senseonics Holdings, Inc. (SENS) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.